Ignite Creation Date:
2025-12-24 @ 4:33 PM
Ignite Modification Date:
2026-02-28 @ 8:50 PM
Study NCT ID:
NCT02502266
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-01
First Post:
2015-07-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-03
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-07-16
Completion Date Type:
ESTIMATED
First Submit Date:
2015-07-17
First Submit QC Date:
None
Study First Post Date:
2015-07-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-10-11
Results First Submit QC Date:
None
Results First Post Date:
2025-05-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-14
Last Update Post Date:
2025-12-01
Last Update Post Date Type:
ESTIMATED